Spire Healthcare Group PLC 37.6% potential upside indicated by JP Morgan Cazenove

Spire Healthcare Group PLC with ticker (LON:SPI) now has a potential upside of 37.6% according to JP Morgan Cazenove.



JP Morgan Cazenove set a target price of 344 GBX for the company, which when compared to the Spire Healthcare Group PLC share price of 250 GBX at opening today (19/04/2024) indicates a potential upside of 37.6%. Trading has ranged between 204 (52 week low) and 322 (52 week high) with an average of 480,484 shares exchanging hands daily. The market capitalisation at the time of writing is £1,006,289,178.

Spire Healthcare Group plc is a United Kingdom-based company that owns and operates private hospitals and clinics in the United Kingdom (UK) and provides a range of private healthcare services. The Company offers a range of treatments and services, such as allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, dental surgery, eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart treatments, neurosurgery and neurology, hip and knee, kidney treatments, physiotherapy, podiatry, respiratory medicine, scans and investigations, skin treatments, spinal surgery and treatments, sports science, vascular surgery, weight loss, women’s health, and others. Its tests and scans include cardiac computerized tomography (CT), CT scans, magnetic resonance imaging (MRI) scans, ultrasound scans, and x-rays.